13G Filing: Great Point Partners and Adamas Pharmaceuticals Inc (ADMS)

Page 8 of 8

Page 8 of 8 – SEC Filing

Exhibit
A

AGREEMENT REGARDING THE
JOINT FILING OF SCHEDULE 13G/A

The undersigned hereby agree
as follows:

(i)        Each of them is individually eligible to use the Schedule 13G/A to which this Exhibit is attached, and such Schedule 13G/A is filed on behalf of each of them; and

(ii)       Each of them is responsible for the timely filing of such Schedule 13G/A and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.

Date: October 10, 2017

GREAT POINT PARTNERS, LLC
By:  /s/ Dr. Jeffrey R. Jay, M.D.
Dr. Jeffrey R. Jay, M.D.,
as senior managing member
  /s/ Dr. Jeffrey R. Jay, M.D.
DR. JEFFREY R. JAY, M.D.
  /s/ Mr. David Kroin
MR. DAVID KROIN

Follow Adamas Pharmaceuticals Inc (NASDAQ:ADMS)

Page 8 of 8